Abstract The 2019 novel coronavirus (COVID-19) has quickly become one of the most dire
international pandemic crises since the 1918 Spanish flu. Evidence for COVID-19 …

COVID‐19: Interim Guidance on Management Pending Empirical Evidence. From an American
Thoracic Society‐led Int Page 1 1 Updated April 3, 2020 COVID‐19: Interim Guidance on …

Background There are many pharmacologic therapies that are being used or considered for
treatment of coronavirus disease 2019 (COVID-19). There is a need for frequently updated …

Effective therapeutic interventions for the treatment and prevention of coronavirus disease
2019 (COVID-19) are urgently needed. A systematic review was conducted to identify …

Background As SARS-CoV-2 continues to spread worldwide, it has already resulted in over
110 million cases and 2.5 million deaths. Currently, there are no effective COVID-19 …

The novel coronavirus SARS-CoV-2, causal agent of COVID-19, quickly spread around the
world resulting in the most aggressive pandemic experienced in over 100 years. Research …

Background: Coronavirus disease 2019 (COVID-19) has rapidly spread worldwide, but safe
and effective treatment options remain unavailable. Numerous systematic reviews of varying …

Background COVID-19 is a rapidly spreading virus infection that has quickly caused
extensive burden to individual, families, countries, and the globe. No intervention has yet …

SARS-CoV-2 (COVID-19) has been changing the world since December 2019. A
comprehensive search into many COVID-19 treatment guidelines was conducted and …

Abstract A novel coronavirus-2 (SARS-CoV-2) was first identified in Wuhan, China, and
quickly spread globally. Several treatments have been proposed, many of which have …